To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Cardiac Dimensions inks $17.5m Series C
Kirkland, Washington-based Cardiac Dimensions, a developer of treatments for functional mitral regurgitation in patients with heart failure, has secured $17.5 million in Series C financing.
